Table 1.
Compound | Effect | Mechanism | Target cell | Reference |
---|---|---|---|---|
Aloe vera extract | Reduced IL-1β | Reduced expression of NLRP3, procaspase-1, and P2X7R Inhibition of ERK, p38, NFκB signaling |
THP-1 and human MF | [51] |
| ||||
Aloe emodin | Reduced IL-1β | Reduced expression of NLRP3, procaspase-1, and ASC expression | BMDM | [52] |
| ||||
Aloe emodin | Enhanced survival | NLRP3-KO mice model of septic shock | [52] | |
| ||||
Curcumin | Reduced IL-1β and caspase-1 inhibition | Reduced ER stress through AMPK | Mouse hippocampus | [53] |
| ||||
Curcumin | Reduced ROS and TXNIP expression | Neuroblastoma cells | [53] | |
| ||||
Curcumin | Reduced IL-1β and caspase-1 inhibition | Lysosome protection | J774A.1 | [54] |
| ||||
Curcumin | Reduced IL-1β | Reduced ROS | BMDM | [54] |
| ||||
Curcumin | Reduced IL-1β | Reduced ROS and lysosome damage Inhibition of ERK1/2 signaling |
Mouse peritoneal MF of septic shock model | [54] |
| ||||
EGCG | Reduced IL-1β and caspase-1 inhibition | Reduced expression of NLRP3 and procaspase-1 and Nrf2 induction | Kidney tissue from SLE mouse model | [55] |
| ||||
EGCG | Reduced IL-1β | Reduced expression of NLRP3 Nrf2 induction |
Rat model of contrast-induced nephropathy | [56] |
| ||||
Genipin | Reduced IL-1β | Reduced expression of NLRP3 | THP-1 | [57] |
| ||||
Genipin | Reduced IL-1β and caspase-1 inhibition | Reduced ASC oligomerization Induced ROS and reduced autophagy |
BMDM NLRP3-KO mice |
[58] |
| ||||
Ginseng | Reduced IL-1β and caspase-1 inhibition | BMDM, THP-1 | [59] | |
| ||||
Ginseng | Reduced IL-1β | Inhibition of iNOS and reduced NO and ROS Reduced S-nitrosylation of NLRP3 and caspase-1 |
RAW264.7, BMDM | [60] |
| ||||
Mangiferin | Reduced IL-1β | Reduced expression of NLRP3 Induced AMPK phosphorylation Reduced ROS and TXNIP expression |
Endothelial cells | [61] |
| ||||
Mangiferin | Reduced IL-1β | Reduced expression of NLRP3, ASC, caspase-1, and iNOS Nrf2 induction |
Murine primary hepatocytes | [62] |
| ||||
Propolis | Reduced IL-1β | Reduced ROS | BMDM | [63] |
| ||||
Quercetin | Reduced IL-1β | Reduced expression of NLRP3, ASC, and caspase-1 | Rat model of streptozotocin- induced diabetic nephropathy | [64] |
| ||||
Quercetin | Reduced IL-1β | Reduced expression of NLRP3, ASC, and caspase-1 | Rat model of fructose-induced hyperuricemia | [65] |
| ||||
Quercetin | Reduced IL-1β and caspase-1 inhibition | Reduced expression of NLRP3, ASC, and caspase-1 Reduced ROS and TXNIP expression |
Hepatocytes from rat model of streptozotocin-induced diabetes | [66] |
| ||||
Quercetin | Reduced IL-1β | Reduced expression of NLRP3, ASC, and caspase-1 Reduced TXNIP expression and NFκB signaling |
Hypothalamus of fructose-fed rat | [67] |
| ||||
Quercetin | Reduced IL-1β | Reduced NLRP3 expression and induced AMPK Reduced ROS and TXNIP expression Inhibition of IKKβ |
Endothelial cells | [68] |
| ||||
Quercetin | Reduced IL-1β | Reduced expression of NLRP3, ASC, and caspase-1 Reduced ROS |
Rat model of spinal cord injury | [69] |
| ||||
Resveratrol | Reduced IL-1β | Reduced NLRP3 expression and induced Sirt1 expression | Human mesenchymal stem cells | [70] |
| ||||
Resveratrol | Reduced IL-1β | Reduced expression of NLRP3 and ASC Reduced P2X7R and COX-2 expression Reduced ROS and p38 signaling |
THP1 | [71] |
| ||||
Resveratrol | Reduced IL-1β | Reduced mtDNA release and increased cAMP Increased p38 and JNK signaling |
J774A.1 | [72] |
| ||||
Resveratrol | Reduced IL-1β | Reduced NLRP3 expression and induced Sirt1 expression | Liver of high fat diet-mice | [73] |
| ||||
Resveratrol | Reduced IL-1β and caspase-1 inhibition | Reduced mtROS Reduced accumulation of acetylated tubulin |
BMDM Mouse model of acute gout |
[50] |
| ||||
Resveratrol | Reduced IL-1β | Reduced NLRP3 expression and induced Sirt1 expression | BV2 cells Hippocampus of septic mice |
[74] |
| ||||
Resveratrol | Reduced IL-1β | Induction of autophagy and AMPK and reduced ROS | Human peritoneal mesothelial cells | [75] |
| ||||
Sulforaphane | Reduced IL-1β and caspase-1 inhibition | BMDM Peritonitis mouse model of acute gout |
[28] | |
| ||||
Sulforaphane | Reduced IL-1β | Reduced STAT1 signaling and induced Nrf2 translocation | THP-1 | [76] |
| ||||
Sulforaphane | Reduced IL-1β and caspase-1 inhibition | Reduced expression of NLRP3, ASC, and caspase-1 Reduced ROS and reduced mitochondrial dysfunction Activation of AMPK and autophagy |
Murine hepatocytes | [77] |